Candidiasis Treatment Market In-Depth Analysis during 2020-2026
Candidiasis is a treatable fungal infection caused by Candida yeasts. Typically, Candida lives within the intestinal tract, but it can also be found on the skin, mouth, or mucous membranes of the human body. Various species of Candida can cause infections in the human population. Health care professionals (HCPs) diagnose and administer candidiasis treatment based on patient’s medical history, physical and laboratory examinations, and symptoms. In recent years, HCPs have observed a steady rise in the incidence of candidiasis infections across the globe. Additionally, due to sound health awareness, candidiasis diagnosis and successful treatment have also witnessed an upward trend. These developments are expected to significantly expand the global candidiasis treatment market, opening the doors to robust innovation and mutually-beneficial partnerships.
Get Sample Copy of
Candidiasis Treatment Market: https://www.fairfieldmarketresearch.com/report/candidiasis-treatment-market/request-sample
Prevalence
of Multiple Types of Candida Spurs Global Market Growth
Multiple types of candidiasis are widely prevalent
among different groups of the human population. The most common
infection-inducing candidiasis species include C. krusie, C. albicans, C. tropicalis, C. glabrata, and C.
parapsilosis. Further, based on types, HCPs classify candidiasis into oropharyngeal
candidiasis, esophagus candidiasis, vaginal candidiasis, and invasive
candidiasis. Among these, invasive candidiasis is the most common fungal
infection in the hospital patient-pool. Whereas, oropharyngeal candidiasis is
highly prevalent among individuals battling with AIDS, cancer patients on
chemotherapy, and infants. Moreover, vaginal candidiasis has evolved into a
common occurrence among women. Given the different age groups, genders, and
pre-medical conditions that candidiasis targets, there exist numerous opportunities
for more reliable treatments and biomedical innovation. Over the forecast
period, this factor is expected to draw substantial growth in the global
candidiasis market.
Major
Leaders in Global Candidiasis Treatment Market
Prominent companies that hold a significant
share in the global candidiasis treatment market include Astellas Pharma Inc.,
Merck KGaA, Amplyx Pharmaceuticals Inc., Grupo Ferrer Internacional, S.A.,
NovaDigm Therapeutics Inc., SCYNEXIS, Inc., Novabiotics Limited, Viamet
Pharmaceuticals Holdings, LLC, Basilea Pharmaceutica Ltd., Cidara Therapeutics,
Inc., and Mycovia Pharmaceuticals Inc.
Biomedical
Innovation and Intense R&D on Fungal Diseases Spur Candidiasis Treatment
Market to Rapid Expansion
The global candidiasis treatment market is
projected to attain profitable outcomes during the forecast period owing to
advanced collaboration on R&D on fungal diseases. In the coming years,
other major market drivers include relative dearth of reliable treatments,
increased economic support from the government, and rise in the usage of
off-label drugs. Despite this, it is anticipated that the candidiasis treatment
market can face challenges from the growing resistance to antifungal drugs.
Current antifungal drugs against some forms of Candida, such as C.
parapsilosis, C. auris, and C. glabrata, have shown varying
levels of resistance. However, robust collaboration amidst the medical
fraternity, government support, and strategic alliances are poised to overcome
this challenge in the near future.
Do You Have Any Query or Specific
Requirement? Request for Custom Research: https://www.fairfieldmarketresearch.com/report/candidiasis-treatment-market/request-customization
North
America and Europe Hold the Largest Market Share
North America, followed by Europe, has emerged
as the foremost region that commands the highest market share across the globe.
This is primarily due to significant investments in healthcare facilities,
biomedical research, and health awareness among the general public. In addition
to these two regions, the candidiasis treatment market of Asia Pacific is
projected to grow at a steady pace. In Asia Pacific, high investments to
develop a modern healthcare infrastructure, coupled with an increase in the
region’s population, contributes to the growth of the candidiasis treatment
market.
Fairfield Market Research is a UK-based
market research provider. Fairfield offers a wide spectrum of services, ranging
from customized reports to consulting solutions. With a strong European
footprint, Fairfield operates globally and helps businesses navigate through
business cycles, with quick responses and multi-pronged approaches. The company
values an eye for insightful take on global matters, ably backed by a team of
exceptionally experienced researchers. With a strong repository of syndicated
market research reports that are continuously published & updated to ensure
the ever-changing needs of customers are met with absolute promptness.
Contact
Fairfield Market Research
London, UK
UK +44 (0)20
30025888
USA (Toll-free) +1 (844) 3829746
Web: https://www.fairfieldmarketresearch.com/
Email: sales@fairfieldmarketresearch.com
Follow Us: LinkedIn
Comments
Post a Comment